AR126471A1 - Derivados de imidazo[1,2-b][1,2,4]triazol para uso terapéutico - Google Patents

Derivados de imidazo[1,2-b][1,2,4]triazol para uso terapéutico

Info

Publication number
AR126471A1
AR126471A1 ARP220101869A ARP220101869A AR126471A1 AR 126471 A1 AR126471 A1 AR 126471A1 AR P220101869 A ARP220101869 A AR P220101869A AR P220101869 A ARP220101869 A AR P220101869A AR 126471 A1 AR126471 A1 AR 126471A1
Authority
AR
Argentina
Prior art keywords
compound
formula
cancer
toluene
palladium
Prior art date
Application number
ARP220101869A
Other languages
English (en)
Spanish (es)
Inventor
Antonio Almario
Peretti Danielle De
Amlie Dommergue
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR126471A1 publication Critical patent/AR126471A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP220101869A 2021-07-16 2022-07-15 Derivados de imidazo[1,2-b][1,2,4]triazol para uso terapéutico AR126471A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21305999 2021-07-16

Publications (1)

Publication Number Publication Date
AR126471A1 true AR126471A1 (es) 2023-10-11

Family

ID=77126712

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101869A AR126471A1 (es) 2021-07-16 2022-07-15 Derivados de imidazo[1,2-b][1,2,4]triazol para uso terapéutico

Country Status (7)

Country Link
US (1) US20240300956A1 (https=)
EP (1) EP4370518A1 (https=)
JP (1) JP2024525791A (https=)
CN (1) CN117916240A (https=)
AR (1) AR126471A1 (https=)
TW (1) TW202321245A (https=)
WO (1) WO2023285466A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3581380B2 (ja) * 1993-08-17 2004-10-27 富士写真フイルム株式会社 アゾメチン色素およびそれを含有する熱転写色素供与材料
US20040010056A1 (en) * 2002-06-28 2004-01-15 Konica Corporation Colored particle dispersion, ink jet ink, dye, and ink jet recording method
FR2928922B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928924B1 (fr) 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2928923B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2950344B1 (fr) * 2009-09-18 2011-11-25 Sanofi Aventis Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique.
EP4370516A1 (en) * 2021-07-16 2024-05-22 Sanofi 6h-imidazo[1,2-a]pyrrolo[2,3-e]pyridine derivatives for use in therapy

Also Published As

Publication number Publication date
US20240300956A1 (en) 2024-09-12
EP4370518A1 (en) 2024-05-22
TW202321245A (zh) 2023-06-01
WO2023285466A1 (en) 2023-01-19
JP2024525791A (ja) 2024-07-12
CN117916240A (zh) 2024-04-19

Similar Documents

Publication Publication Date Title
Yan et al. An efficient one-pot synthesis of heterocycle-fused 1, 2, 3-triazole derivatives as anti-cancer agents
AR126854A1 (es) Compuestos macrocíclicos para el tratamiento de cáncer
JP2022515198A5 (https=)
JP2008535902A5 (https=)
DK1583524T3 (da) Bis(thiohydrazidamid)-forbindelser til behandling af multilægemiddel-resistent cancer
JP2016537382A5 (https=)
EP1533292A4 (en) DIBENZYLAMINE COMPOUND AND THEIR MEDICAL USE
JP2008535903A5 (https=)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
CY1111834T1 (el) Παραγωγα της 4-(2-αμινο-1-hydroxyethyl)phenol σαν αγωνιστικa του αδρενεργικου (adrenergic) ληπτη βητα -2
AR056186A1 (es) Compuesto de imidazo[1,2-a]piridinilo, su uso para la fabricacion de un medicamento y formulacion farmaceutica que lo comprende
JP2017531041A5 (https=)
ES2862314T3 (es) Compuestos de imidazo[1,2-a]piridina, composiciones que los comprenden, métodos para el tratamiento de enfermedades que los utilizan y métodos para prepararlos
SE0001438D0 (sv) New chemical compounds and their use in therapy
JP2014521609A5 (https=)
JP4707393B2 (ja) 抗癌化合物
JP2017506267A5 (https=)
AR126471A1 (es) Derivados de imidazo[1,2-b][1,2,4]triazol para uso terapéutico
WO2012007619A1 (es) Proceso de obtención de derivados solubles en agua de 20(s)camptotecina como agentes antitumorales
JP2017502039A (ja) 放射性標識のための方法および試薬
JP2005531563A5 (https=)
CN112898213B (zh) 一种多取代1,3-二烯支撑的环化合物及其用途
RU2011129771A (ru) Противораковые соединения
CN101012213A (zh) 一类染料木素的衍生物及其制法和用途
CN107200748A (zh) 含氟二氢杨梅素衍生物及其制备方法和应用

Legal Events

Date Code Title Description
FA Abandonment or withdrawal